Form 4: Personalis CFO and COO, Aaron Tachibana, Reports Stock Option Grant

Aaron Tachibana, CFO and COO of Personalis, Inc., reports the acquisition of stock options.

Summary

• On March 15, 2024, Aaron Tachibana, the CFO and COO of Personalis, Inc., was granted stock options to purchase 175,000 shares of common stock.
• The exercise price of the options is $1.61 per share.
• The options vest in 36 equal monthly installments, beginning on April 15, 2024.
• The options expire on March 15, 2034.
• Following the transaction, Tachibana directly owns derivative securities for 175,000 shares.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard executive compensation practice. The grant itself is neither overwhelmingly positive nor negative.

Positives

• The grant of stock options to a key executive like the CFO and COO can align their interests with those of the shareholders, incentivizing them to improve the company's performance.

Industry Context

Stock option grants are a common form of executive compensation in the technology and biotechnology industries, used to attract and retain talent and align their interests with those of shareholders.

Comparison to Industry Standards

• Stock option grants are a standard component of executive compensation packages in the biotech industry.
• The vesting schedule of 36 months is also typical.
• The size of the grant would be benchmarked against similar companies based on market capitalization and executive role.

Stakeholder Impact

• The stock option grant could potentially dilute existing shareholders if the options are exercised.
• The grant incentivizes the CFO and COO to increase shareholder value.

Key Dates